Laird Norton Trust Company, LLC Inmune Bio, Inc. Transaction History
Laird Norton Trust Company, LLC
- $709 Million
- Q2 2024
A detailed history of Laird Norton Trust Company, LLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Laird Norton Trust Company, LLC holds 31,500 shares of INMB stock, worth $169,785. This represents 0.04% of its overall portfolio holdings.
Number of Shares
31,500
Previous 31,500
-0.0%
Holding current value
$169,785
Previous $370,000
25.14%
% of portfolio
0.04%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding INMB
# of Institutions
61Shares Held
4.66MCall Options Held
80KPut Options Held
41.8K-
Black Rock Inc. New York, NY813KShares$4.38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA628KShares$3.39 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$3.21 Million45.87% of portfolio
-
Praetorian Pr LLC Rincon, PR485KShares$2.61 Million1.57% of portfolio
-
Geode Capital Management, LLC Boston, MA323KShares$1.74 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $96.7M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...